Covalon Technologies Ltd. (COV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Covalon Technologies Ltd. (COV) has a cash flow conversion efficiency ratio of 0.218x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$5.75 Million ≈ $4.16 Million USD) by net assets (CA$26.39 Million ≈ $19.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Covalon Technologies Ltd. (COV) balance sheet quality index to measure how much of total assets are equity-financed.
Covalon Technologies Ltd. - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Covalon Technologies Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check COV cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Covalon Technologies Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Covalon Technologies Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pacgold Ltd
AU:PGO
|
-0.032x |
|
Metalpha Technology Holding Limited
NASDAQ:MATH
|
0.310x |
|
ICD Co. Ltd
KQ:040910
|
-0.043x |
|
Libental
TA:LBTL
|
-2.455x |
|
ALANDEQGRP FPO
AU:AEG
|
-1.327x |
|
Claranova SE
PA:CLA
|
-1.143x |
|
Ashmore Asset Management Indonesia
JK:AMOR
|
0.001x |
|
GenMont Biotech Inc
TW:3164
|
0.011x |
Annual Cash Flow Conversion Efficiency for Covalon Technologies Ltd. (2005–2025)
The table below shows the annual cash flow conversion efficiency of Covalon Technologies Ltd. from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Covalon Technologies Ltd..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | CA$30.73 Million ≈ $22.23 Million |
CA$2.29 Million ≈ $1.66 Million |
0.075x | -41.00% |
| 2024-09-30 | CA$27.50 Million ≈ $19.90 Million |
CA$3.47 Million ≈ $2.51 Million |
0.126x | +174.53% |
| 2023-09-30 | CA$18.79 Million ≈ $13.59 Million |
CA$-3.18 Million ≈ $-2.30 Million |
-0.169x | +48.65% |
| 2022-09-30 | CA$24.23 Million ≈ $17.53 Million |
CA$-7.99 Million ≈ $-5.78 Million |
-0.330x | -1872.06% |
| 2021-09-30 | CA$33.37 Million ≈ $24.14 Million |
CA$621.37K ≈ $449.49K |
0.019x | +104.21% |
| 2020-09-30 | CA$9.11 Million ≈ $6.59 Million |
CA$-4.03 Million ≈ $-2.91 Million |
-0.442x | -133.57% |
| 2019-09-30 | CA$14.93 Million ≈ $10.80 Million |
CA$-2.83 Million ≈ $-2.04 Million |
-0.189x | -278.94% |
| 2018-09-30 | CA$13.12 Million ≈ $9.49 Million |
CA$-655.47K ≈ $-474.16K |
-0.050x | -3061.17% |
| 2017-09-30 | CA$8.98 Million ≈ $6.50 Million |
CA$15.15K ≈ $10.96K |
0.002x | +100.63% |
| 2016-09-30 | CA$3.81 Million ≈ $2.75 Million |
CA$-1.03 Million ≈ $-742.05K |
-0.269x | +43.16% |
| 2015-09-30 | CA$4.79 Million ≈ $3.46 Million |
CA$-2.27 Million ≈ $-1.64 Million |
-0.474x | -184.43% |
| 2014-09-30 | CA$5.53 Million ≈ $4.00 Million |
CA$3.10 Million ≈ $2.24 Million |
0.561x | +211.29% |
| 2013-09-30 | CA$2.95 Million ≈ $2.13 Million |
CA$-1.49 Million ≈ $-1.07 Million |
-0.504x | +50.18% |
| 2012-09-30 | CA$3.23 Million ≈ $2.34 Million |
CA$-3.27 Million ≈ $-2.37 Million |
-1.012x | -113.61% |
| 2011-09-30 | CA$7.02 Million ≈ $5.07 Million |
CA$-3.32 Million ≈ $-2.40 Million |
-0.474x | -6063.75% |
| 2010-09-30 | CA$7.57 Million ≈ $5.48 Million |
CA$-58.20K ≈ $-42.10K |
-0.008x | +98.20% |
| 2009-09-30 | CA$10.94 Million ≈ $7.91 Million |
CA$-4.67 Million ≈ $-3.38 Million |
-0.427x | -131.81% |
| 2008-09-30 | CA$15.02 Million ≈ $10.86 Million |
CA$-2.76 Million ≈ $-2.00 Million |
-0.184x | -2114.69% |
| 2007-09-30 | CA$17.59 Million ≈ $12.73 Million |
CA$-146.21K ≈ $-105.77K |
-0.008x | +97.04% |
| 2006-09-30 | CA$8.27 Million ≈ $5.98 Million |
CA$-2.32 Million ≈ $-1.68 Million |
-0.281x | -13.16% |
| 2005-09-30 | CA$3.79 Million ≈ $2.74 Million |
CA$-941.80K ≈ $-681.28K |
-0.248x | -- |
About Covalon Technologies Ltd.
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more